Interleukin-1 receptor-associated kinase M-deficient mice demonstrate an improved host defense during Gram-negative

Jacobien J Hoogerwerf1, Gerritje J W van der Windt, Dana C Blok

  • 1Center for Infection and Immunity Amsterdam, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.

Insights

Interleukin-1 receptor (IL-1R)-associated kinase (IRAK)-M impairs host defense against Klebsiella pneumoniae pneumonia. Eliminating IRAK-M in mice improved bacterial clearance, reduced tissue damage, and increased survival rates.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Pulmonology

Background:

  • Pneumonia is a leading cause of death and sepsis, often caused by bacterial pathogens.
  • Innate immunity, particularly toll-like receptor (TLR) signaling, is crucial for combating bacterial invasion.
  • Interleukin-1 receptor (IL-1R)-associated kinase (IRAK)-M is an inhibitor of TLR signaling found in lung epithelial cells and macrophages.

Purpose of the Study:

  • To investigate the role of IRAK-M in the host defense against bacterial pneumonia.
  • To determine the impact of IRAK-M deficiency on the response to Klebsiella pneumoniae infection.

Main Methods:

  • Comparison of wild-type (WT) and IRAK-M-deficient (IRAK-M(-/-)) mice infected intranasally with Klebsiella pneumoniae.
  • Assessment of bacterial load, dissemination, tissue injury, survival rates, and inflammatory markers in the lungs.
  • In vitro analysis of macrophage responsiveness to K. pneumoniae and lipopolysaccharide (LPS).

Main Results:

  • IRAK-M mRNA was upregulated in WT mice during Klebsiella pneumonia.
  • IRAK-M(-/-) mice exhibited reduced bacterial growth, less dissemination, diminished tissue injury, and improved survival.
  • IRAK-M(-/-) alveolar macrophages showed enhanced in vitro responsiveness, but in vivo cytokine/chemokine levels were not increased.
  • Lung inflammation was elevated in IRAK-M(-/-) mice early post-infection.

Conclusions:

  • IRAK-M plays a detrimental role in host defense against Klebsiella pneumoniae pneumonia.
  • IRAK-M deficiency enhances bacterial clearance and survival, despite increased early inflammation.
  • Targeting IRAK-M may represent a therapeutic strategy for bacterial pneumonia.

Related Concept Videos